FMFatima Mostefai

Fatima Mostefai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fatima Mostefai has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines

    by Kevin A. Kovalchik, David J. Hamelin, Peter Kubiniok, Benoîte Bourdin, Fatima Mostefai, Raphaël Poujol, Bastien Paré, Shawn M. Simpson, John Sidney, Éric Bonneil, et al.

    Next-generation T-cell-directed vaccines for COVID-19 focus on establishing lasting T-cell immunity against current and emerging SARS-CoV-2 variants. Precise identification of conserved T-cell epitopes is critical for designing effective vaccines. Here we introduce a comprehensive computational framework incorporating a machine learning algorithm—MHCvalidator—to enhance mass spectrometry-based immunopeptidomics sensitivity. MHCvalidator identifies unique T-cell epitopes presented by the B7 supertype, including an epitope from a + 1-frameshift in a truncated Spike antigen, supported by ribosome profiling. Analysis of 100,512 COVID-19 patient proteomes shows Spike antigen truncation in 0.85% of cases, revealing frameshifted viral antigens at the population level. Our EpiTrack pipeline tracks global mutations of MHCvalidator-identified CD8 + T-cell epitopes from the BNT162b4 vaccine. While most vaccine epitopes remain globally conserved, an immunodominant A*01-associated epitope mutates in Delta and Omicron variants. This work highlights SARS-CoV-2 antigenic features and emphasizes the importance of continuous adaptation in T-cell vaccine development.


  • Open Access

    Refining SARS-CoV-2 Intra-host Variation by Leveraging Large-scale Sequencing Data

    by Fatima Mostefai, Jean-Christophe Grenier, Raphäel Poujol, Julie G. Hussin

    Understanding the evolution of viral genomes is essential for elucidating how viruses adapt and change over time. Analyzing intra-host single nucleotide variants (iSNVs) provides key insights into the mechanisms driving the emergence of new viral lineages, which are crucial for predicting and mitigating future viral threats. Despite the potential of next-generation sequencing (NGS) to capture these iSNVs, the process is fraught with challenges, particularly the risk of capturing sequencing artifacts that may result in false iSNVs. To tackle this issue, we developed a workflow designed to enhance the reliability of iSNV detection in large heterogeneous collections of NGS libraries. We use over 130,000 publicly available SARS-CoV-2 NGS libraries to show how our comprehensive workflow effectively distinguishes emerging viral mutations from sequencing errors. This approach incorporates rigorous bioinformatics protocols, stringent quality control metrics, and innovative usage of dimensionality reduction methods to generate representations of this high-dimensional dataset. We identified and mitigated batch effects linked to specific sequencing centers around the world and introduced quality control metrics that consider strand coverage imbalance, enhancing iSNV reliability. Additionally, we pioneer the application of the PHATE visualization approach to genomic data and introduce a methodology that quantifies how related groups of data points are within a two-dimensional space, enhancing our ability to explain clustering patterns based on their shared genetic characteristics. Our workflow sheds light on the complexities of viral genomic analysis with state-of-the-art sequencing technologies and advances the detection of accurate intra-host mutations, opening the door for an enhanced understanding of viral adaptation mechanisms.

  • Open Access

    Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis

    by Arnaud N’guessan, Senthilkumar Kailasam, Fatima Mostefai, Raphael Poujol, Jean-Christophe Grenier, Paola Contini, Raffaele De Palma, Carsten Haber, Volker Stadler, Guillaume Bourque, et al.

    A deeper understanding of the molecular determinants that drive humoral responses to coronaviruses, and in particular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is critical for improving and developing diagnostics, therapies and vaccines. Moreover, viral mutations can change key antigens in a manner that alters the ability of the immune system to detect and clear infections. In this study, we exploit a deep serological profiling strategy coupled with an integrated, computational framework for the analysis of SARS-CoV-2 humoral immune responses of asymptomatic or recovered COVID-19-positive patients relative to COVID-19-negative patients. We made use of a novel high-density peptide array (HDPA) spanning the entire proteomes of SARS-CoV-2 and endemic human coronaviruses to rapidly identify B cell epitopes recognized by distinct antibody isotypes in patients’ blood sera. Using our integrated computational pipeline, we then evaluated the fine immunological properties of detected SARS-CoV-2 epitopes and relate them to their evolutionary and structural properties. While some epitopes are common across all CoVs, others are private to specific hCoVs. We also highlight the existence of hotspots of pre-existing immunity and identify a subset of cross-reactive epitopes that contributes to increasing the overall humoral immune response to SARS-CoV-2. Using a public dataset of over 38,000 viral genomes from the early phase of the pandemic, capturing both inter- and within-host genetic viral diversity, we determined the evolutionary profile of epitopes and the differences across proteins, waves and SARS-CoV-2 variants, which have important implications for genomic surveillance and vaccine design. Lastly, we show that mutations in Spike and Nucleocapsid epitopes are under stronger selection between than within patients, suggesting that most of the selective pressure for immune evasion occurs upon transmission between hosts.